<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662295/" ref="ordinalpos=3604&amp;ncbi_uid=1759031&amp;link_uid=PMC2662295" image-link="/pmc/articles/PMC2662295/figure/fig5/" class="imagepopup">FIGURE 5. From: TRAF6 and MEKK1 Play a Pivotal Role in the RIG-I-like Helicase Antiviral  <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody"><b>A model for TRAF6- and MEKK1-mediated signal for IFN-β production  in the RLH/IPS-1 signaling pathway.</b> Upon recognition of intracellular  dsRNA by RIG-I or MDA5, RLHs recruit IPS-1 through CARD domains, which induces  interaction between IPS-1 and TRAF3, TRAF6, FADD, and RIP1. TRAF3 activates  TBK1/IKK-i, leading to the activation of IRF3, whereas TRAF6 may  interact with MEKK1, which in turn contributes to the activation of IKK and  MAPKK, subsequently activates NF-κB and AP-1, respectively. These  transcription factors cooperatively activate the IFN-β promoter.</div></div>